AbbVie Inc (NYSE:ABBV)

54.08
Data as of Jul 24
 -0.40 / -0.73%
Today’s Change
42.25
Today|||52-Week Range
58.27
+2.40%
Year-to-Date
Stocks: 6 things to know before the open
5:30am / CNNMoney.com
Investors Focus On Earnings Rather Than Geopolitical Tensions
Jul 18 / Benzinga
Shire, ArmaGen Ink Licensing Agreeement for AGT-182 - Analyst Blog
Jul 24 / Zacks.com
With Shire, Did AbbVie Count Its Chickens Before They Hatched?
Jul 18 / MotleyFool.com
Obama call for US corporate tax crackdown
Jul 24 / FT.com
AbbVie Inc. Wins the Shire
Jul 18 / MotleyFool.com
Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Zacks Analyst Interviews
Jul 24 / Zacks.com
Could AbbVie's Buyout of Shire Make It a New Dividend Aristocrat?
Jul 18 / TheStreet.com
Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Industry Outlook
Jul 24 / Zacks.com
Stock Market Today: Markets Shrug Off Escalating Geopolitical Conflict to Close Highe...
Jul 18 / TheStreet.com
Will AbbVie (ABBV) Surprise This Earnings Season? - Analyst Blog
Jul 24 / Zacks.com
Shire chief's $10m 'golden hello' at AbbVie
Jul 18 / FT.com
Glaxo (GSK) Slips on Disappointing Q2 Earnings, Cuts View - Analyst Blog
Jul 24 / Zacks.com
What You Need to Know About Johnson & Johnson's Best-Selling Drugs
Jul 18 / MotleyFool.com
#PreMarket Primer: Thursday, July 24: Facebook Proves Its Worth
Jul 24 / Benzinga
Shire demands assurances in backroom fight over tax inversion
Jul 18 / FT.com
Gilead Stock's Great Expectations and Giant Opportunity
Jul 23 / MotleyFool.com
Shire Agrees to AbbVie $55B Takeover Offer
Jul 18 / TheStreet.com
Biotech Stock Roundup: AbbVie's Tax Inversion, Amgen Drug Scores in Phase 3 - Analyst...
Jul 23 / Zacks.com
What crisis? U.S. stocks soar
Jul 18 / CNNMoney.com
Why Corporate Inversion Is More Than a Political Punching Bag
Jul 23 / TheStreet.com
Stock Market Today: Stocks Rebound Despite Geopolitical Unrest
Jul 18 / TheStreet.com
Healthcare Spending Uptrend: 3 Medical Stocks for Strong Growth - Analyst Blog
Jul 23 / Zacks.com
Benzinga's Top #PreMarket Losers
Jul 18 / Benzinga
Johnson & Johnson Announces $5B Share Buyback - Analyst Blog
Jul 22 / Zacks.com
How Will AbbVie (ABBV) Stock React To Merger With Shire Pharmaceuticals (SHPG)
Jul 18 / TheStreet.com
Allergan, a Valeant Takeover Target, Plans 1,500 Job Cuts - Analyst Blog
Jul 22 / Zacks.com
Stock Market Today: Futures Rise Despite Malaysia Air Crash, Gaza Invasion
Jul 18 / TheStreet.com
3 Things You Need to Watch on Gilead Sciences Inc. Earnings Call
Jul 22 / MotleyFool.com
Today's Top Health Care Stocks to Watch: AbbVie, Gentiva Health Services and Shire
Jul 18 / MotleyFool.com
3 Quotes From Johnson & Johnson's Conference Call You Need to Read
Jul 22 / MotleyFool.com
Drugmaker in $54.7 billion merger aimed at cutting U.S. taxes
Jul 18 / CNNMoney.com
Shire's Q2 Earnings Strong but Overshadowed by AbbVie Deal - Analyst Blog
Jul 22 / Zacks.com
AbbVie seals B#32bn takeover of Shire
Jul 18 / FT.com
#PreMarket Primer: Tuesday, July 22: Separatists Hand Over Remains From Malaysian Air...
Jul 22 / Benzinga
July 18 Premarket Briefing: 10 Things You Should Know
Jul 18 / TheStreet.com
Here's What You Need to Know About AbbVie and GlaxoSmithKline's Upcoming Earnings
Jul 22 / MotleyFool.com
AbbVie to Acquire Shire for B#24.44 in Cash and 0.8960 New AbbVie Shares
Jul 18 / Benzinga
AbbVie Set to Acquire UK-Based Shire in Q4 - Analyst Blog
Jul 21 / Zacks.com
Stocks: 5 things to know before the open
Jul 18 / CNNMoney.com
Pfizer's Stock Falls Ill as the Dow Tumbles
Jul 21 / MotleyFool.com
European Stocks Fall on Increased Tensions in Ukraine, the Middle East
Jul 18 / TheStreet.com
Welcome to Ireland, AbbVie
Jul 21 / MotleyFool.com
Banks lead broad FTSE 100 losses
Jul 18 / FT.com
ABBV, MRK And PFE, Pushing Health Care Sector Downward
Jul 21 / TheStreet.com
Repros Gets Additional FDA Guidance for Androxal - Analyst Blog
Jul 17 / Zacks.com
Allergan Beats on Q2 Earnings, Ups View & Plans 13% Job Cut - Analyst Blog
Jul 21 / Zacks.com
Eli Lilly and Immunocore Collaborate to Develop Cancer Drugs - Analyst Blog
Jul 17 / Zacks.com
Monday Links: Excessive Valuations
Jul 21 / StockTwits
AbbVie set to unveil B#31bn Shire takeover
Jul 17 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.